MOTIVATORS FOR SMOKING CESSATION AND KNOWLEDGE AND PERCEPTION OF SMOKING RISKS/CONSEQUENCES AMONG PEOPLE WITH SCHIZOPHRENIA COMPARED TO NORMAL CONTROLS
Deanna L. Kelly(University of Maryland, Baltimore), Stephen J. Heishman(National Institute on Drug Abuse), Suzanne Lo(National Institute on Drug Abuse), Eric T. Moolchan(National Institute on Drug Abuse), Katherine Wright(Northwestern University), Stephanie Feldman(University of Maryland, Baltimore), Douglas L. Boggs(Yale University), Fang Liu(University of Maryland, Baltimore), Charles Richardson(Los Alamos National Laboratory), Heidi J. Wehring(University of Maryland, Baltimore), Heather Gallagher(University of Maryland, Baltimore), Robert P. McMahon(Valneva (Austria))
Cited by 2
Related Papers
The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements
|Schizophrenia Bulletin|2009|915
Methamphetamine and Amphetamine Pharmacokinetics in Oral Fluid and Plasma after Controlled Oral Methamphetamine Administration to Human Volunteers
|Clinical Chemistry|2003|264
Olanzapine Compared With Chlorpromazine in Treatment-Resistant Schizophrenia
|American Journal of Psychiatry|1998|245